x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

touchPODCAST

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare

science

All Episodes

01:01:33

Treatment of endometrial cancer: Highlights from ESGO...

touchPODCAST ·

2023/10/19

touchCONGRESS for touchONCOLOGY Listen to renowned experts in gynaecological oncology Prof. Nicole Concin, Dr Mansoor Raza Mirza and Dr Sandro Pignata review key data presented at ESGO 2023 on recent key developments in the management of patients with endometrial cancer. Aspects covered include the importance of molecular characterization and the latest clinical data for new and emerging agents, including immunotherapies and other agents, in the treatment of advanced or recurrent endometrial cancer

en

37:39

Practical considerations for personalized medicine in...

touchPODCAST ·

2023/10/19

touchEXPERT OPINIONS for touchONCOLOGY A leading expert explores the importance of molecular pathology and individual patient profiles in guiding personalized medicine in thyroid cancer to deliver optimal outcomes. The expert Prof. Marcia Brose, Jefferson Torresdale Hospital, Philadelphia, PA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Bayer HealthCare Pharmaceuticals Inc. This activity is jointly provided by USF Health and

en

37:40

Practical considerations for personalized medicine in...

touchPODCAST ·

2023/10/19

touchEXPERT OPINIONS for touchENDOCRINOLOGY A leading expert explores the importance of molecular pathology and individual patient profiles in guiding personalized medicine in thyroid cancer to deliver optimal outcomes. The expert Prof Marcia Brose, Jefferson Torresdale Hospital, Philadelphia, PA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Bayer HealthCare Pharmaceuticals Inc. This activity is jointly provided by USF Health and

en

37:15

Personalized therapy for NSCLC: Biomarker testing,...

touchPODCAST ·

2023/10/05

touchIN CONVERSATION for touchONCOLOGY Listen to Dr Yasushi Goto (National Cancer Center Hospital, Tokyo, Japan) in conversation with Professor Paul Paik (Memorial Sloan Kettering Cancer Center, New York, USA) on how to optimize the management of patients with NSCLC and MET alterations. In Part 1 they respond to questions from the oncology and respiratory clinical communities on: Biomarker testing in advanced NSCLC Identifying patients with METex14 skipping mutations Targeting METex14 skipping

en

37:14

Personalized therapy for NSCLC: Biomarker testing,...

touchPODCAST ·

2023/10/05

touchIN CONVERSATION for touchRESPIRATORY Listen to Dr Yasushi Goto (National Cancer Center Hospital, Tokyo, Japan) in conversation with Professor Paul Paik (Memorial Sloan Kettering Cancer Center, New York, USA) on how to optimize the management of patients with NSCLC and MET alterations. In Part 1 they respond to questions from the oncology and respiratory clinical communities on: Biomarker testing in advanced NSCLC Identifying patients with METex14 skipping mutations Targeting METex14 skipping

en

32:16

COVID-19 vaccination: What have we learned and what...

touchPODCAST ·

2023/10/04

touchTALKS for touchINFECTIOUS DISEASES Listen to a leading expert from the Middle East address the issue of vaccine equity in COVID-19 vaccination, including the consequences of vaccine inequity and improving communication with the public. The expert: Prof. Nada Melhem, American University of Beirut, Lebanon This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Moderna, Inc. This activity is jointly provided by USF Health and touchIME. This

en

37:03

COVID-19 vaccination: What have we learned and what...

touchPODCAST ·

2023/10/04

touchTALKS for touchINFECTIOUS DISEASES Listen to a leading expert from Africa address the issue of vaccine equity in COVID-19 vaccination, including the consequences of vaccine inequity and improving communication with the public. The expert: Dr Adidja Amani, University of Yaoundé I, Cameroon This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Moderna, Inc. This activity is jointly provided by USF Health and touchIME. This episode is Chapter

en

33:36

The mRNA vaccine platform: A novel tool for the rapid...

touchPODCAST ·

2023/09/21

touchEXPERT OPINIONS for touchINFECTIOUS DISEASES Listen to three leading experts explore mRNA vaccine platforms for respiratory viruses, including their design, clinical application and future prospects. The experts Dr Anna Blakney – University of British Columbia, Vancouver, BC, Canada Prof. Dr. med. Oliver Cornely – University of Cologne, Germany Prof. Ann R Falsey – University of Rochester School of Medicine, New York, NY, USA This touchPODCAST is for HCPs only. This activity is funded by an

en

33:35

The mRNA vaccine platform: A novel tool for the rapid...

touchPODCAST ·

2023/09/21

touchEXPERT OPINIONS for touchRESPIRATORY Listen to three leading experts explore mRNA vaccine platforms for respiratory viruses, including their design, clinical application and future prospects. The experts Dr Anna Blakney – University of British Columbia, Vancouver, BC, Canada Prof. Dr. med. Oliver Cornely – University of Cologne, Germany Prof. Ann R Falsey – University of Rochester School of Medicine, New York, NY, USA This touchPODCAST is for HCPs only. This activity is funded by an

en

32:40

Optimizing androgen deprivation therapy (ADT) in...

touchPODCAST ·

2023/09/14

touchEXPERT OPINIONS for touchONCOLOGY An oncologist, a nurse and a urologist share their insights on the risks and benefits of androgen deprivation therapy, the barriers to equitable care and how to improve treatment adherence for patients with prostate cancer. The experts Dr Tanya Dorff, City of Hope Comprehensive Cancer Center, Duarte, CA, USA Ms Brenda Martone, Northwestern Medicine, Chicago, IL, USA Dr Stephen Freedland, Cedars-Sinai, Los Angeles, CA, USA This touchPODCAST is for HCPs only

en

33:29

Optimizing IOL selection Focus on IOL calculations in...

touchPODCAST ·

2023/09/11

touchIN CONVERSATION for touchOPHTHALMOLOGY In this activity, listen to ophthalmology experts, Prof. Sumit Garg and Dr Karolinne Rocha, respond to questions from the ophthalmology community on IOL selection in cataract patients, focusing on the preoperative assessment of ocular health, optimizing IOL calculations, and the impact of previous surgeries on lens selection. This touchPODCAST is for healthcare professionals only. This activity is funded by an independent medical education grant from

en

20:01

Anti-CGRP antibody preventive treatment of migraine:...

touchPODCAST ·

2023/08/30

touchCLINICAL PERSPECTIVES for touchNEUROLOGY Listen to two case-based interviews with migraine specialists focusing on preventive treatment of migraine with anti-CGRP antibodies. In the first, a clinical expert shares his perspectives on treatment failure in patients with migraine, providing insights and guidance, while the second discussion considers different clinical scenarios to focus on practical management. The experts: Prof. Christian Lampl, Konventhospital Barmherzige Brüder, Linz,

en

36:37

The complement system in NMOSD and MG: A target for...

touchPODCAST ·

2023/08/15

touchPANEL DISCUSSION for touchOPHTHALMOLOGY Listen to a panel of leading experts discuss the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice. The experts Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA Prof. Heinz Wiendl, University Hospital Münster, Münster,

en

36:35

The complement system in NMOSD and MG: A target for...

touchPODCAST ·

2023/08/15

touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to a panel of leading experts discuss the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice. The experts Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA Prof. Heinz Wiendl, University Hospital Münster, Münster, Germany Dr

en

36:34

The complement system in NMOSD and MG: A target for...

touchPODCAST ·

2023/08/15

touchPANEL DISCUSSION for touchNEUROLOGY Listen to a panel of leading experts discuss the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice. The experts Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA Prof. Heinz Wiendl, University Hospital Münster, Münster, Germany Dr

en

39:21

Contemporary insights on sickle cell disease...

touchPODCAST ·

2023/08/15

touchPANEL DISCUSSION for touchRESPIRATORY Listen to three expert haematologists discuss the management of complications of sickle cell disease, as well as recent advances in therapy. The experts Prof. Biree Andemariam, Farmington, CT, USA Prof. Modupe Idowu, Houston, TX, USA Prof. Mark C Walters, Oakland, CA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Agios Pharmaceuticals Inc., Pfizer and Vertex Pharmaceuticals. This activity is

en

39:20

Contemporary insights on sickle cell disease...

touchPODCAST ·

2023/08/15

touchPANEL DISCUSSION for touchNEUROLOGY Listen to three expert haematologists discuss the management of complications of sickle cell disease, as well as recent advances in therapy. The experts Prof. Biree Andemariam, Farmington, CT, USA; Prof. Modupe Idowu, Houston, TX, USA; Prof. Mark C Walters, Oakland, CA, USA; This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Agios Pharmaceuticals Inc., Pfizer and Vertex Pharmaceuticals. This activity

en

39:21

Contemporary insights on sickle cell disease...

touchPODCAST ·

2023/08/15

touchPANEL DISCUSSION for touchCARDIO Listen to three expert haematologists discuss the management of complications of sickle cell disease, as well as recent advances in therapy. The experts Prof. Biree Andemariam, Farmington, CT, USA; Prof. Modupe Idowu, Houston, TX, USA; Prof. Mark C Walters, Oakland, CA, USA; This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Agios Pharmaceuticals Inc., Pfizer and Vertex Pharmaceuticals. This activity is

en

39:20

Contemporary insights on sickle cell disease...

touchPODCAST ·

2023/08/14

touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to three expert haematologists discuss the management of complications of sickle cell disease, as well as recent advances in therapy. The experts Prof. Biree Andemariam, Farmington, CT, USA; Prof. Modupe Idowu, Houston, TX, USA; Prof. Mark C Walters, Oakland, CA, USA; This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Agios Pharmaceuticals Inc., Pfizer and Vertex Pharmaceuticals. This activity

en

35:03

New and emerging agents in HER2-negative metastatic...

touchPODCAST ·

2023/08/14

touchPANEL DISCUSSION for touchONCOLOGY Listen to three breast cancer experts discuss the expanding targeted treatment options for HER2-negative metastatic breast cancer, with a focus on approved and emerging antibody drug conjugates and considerations for their use in clinical practice. The experts Prof. Giuseppe Curigliano, University of Milan, Milan, Italy Prof. Hope Rugo, University of California, San Francisco, CA, USA Prof. Peter Schmid, Barts Cancer Institute, London, UK This touchPODCAST

en

532 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter